Ladenburg Thalmann Financial Services’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$11K	Buy	5,000 +500	+11%	+$987	﹤0.01%	4463
2019 Q3	$8K	Hold	4,500	–	–	﹤0.01%	4510
2019 Q2	$7K	Sell	4,500 -500	-10%	-$875	﹤0.01%	4601
2019 Q1	$10K	Sell	5,000 -1,600	-24%	-$3.39K	﹤0.01%	4388
2018 Q4	$9K	Buy	6,600 +500	+8%	+$915	﹤0.01%	4361
2018 Q3	$15K	Sell	6,100 -500	-8%	-$1.48K	﹤0.01%	4079
2018 Q2	$28K	Hold	6,600	–	–	﹤0.01%	3645
2018 Q1	$28K	Hold	6,600	–	–	﹤0.01%	3645
2017 Q4	$22K	Sell	6,600 -500	-7%	-$1.82K	﹤0.01%	3742
2017 Q3	$27K	Hold	7,100	–	–	﹤0.01%	3512
2017 Q2	$31K	Hold	7,100	–	–	﹤0.01%	3343
2017 Q1	$26K	Hold	7,100	–	–	﹤0.01%	3391
2016 Q4	$19K	Sell	7,100 -500	-7%	-$1.55K	﹤0.01%	3523
2016 Q3	$25K	Hold	7,600	–	–	﹤0.01%	3258
2016 Q2	$25K	Sell	7,600 -1,400	-16%	-$3.44K	﹤0.01%	3200
2016 Q1	$22K	Sell	9,000 -500	-5%	-$1.18K	﹤0.01%	3192
2015 Q4	$31K	Sell	9,500 -500	-5%	-$1.68K	﹤0.01%	2924
2015 Q3	$34K	Sell	10,000 -130	-1%	-$302	﹤0.01%	2743
2015 Q2	$13K	Hold	10,130	–	–	﹤0.01%	3527
2015 Q1	$8K	Sell	10,130 -500	-5%	-$236	﹤0.01%	3775
2014 Q4	$4K	Sell	10,630 -770	-7%	-$1.64K	﹤0.01%	3846
2014 Q3	$50K	Hold	11,400	–	–	﹤0.01%	2032
2014 Q2	$56K	Sell	11,400 -1,000	-8%	-$5.15K	﹤0.01%	1977
2014 Q1	$68K	Hold	12,400	–	–	﹤0.01%	1748
2013 Q4	$75K	Hold	12,400	–	–	﹤0.01%	1649
2013 Q3	$82K	Buy	+12,400	New	+$81K	﹤0.01%	1503

Other funds holding NYMX

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return

Ladenburg Thalmann Financial Services's NYMX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Nymox Pharmaceutical Corp (NYMX) stake by 11% in Q4 2019, buying an estimated $987 and bringing the position to 5,000 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #4463.

Ladenburg Thalmann Financial Services first reported a position in NYMX in Q3 2013 and has held it in 26 quarters since. The position peaked at $82K in Q3 2013. 45 funds tracked by Wall St. Rank hold NYMX as of Q4 2019.

Ladenburg Thalmann Financial Services held 5,000 shares of Nymox Pharmaceutical Corp worth $11K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 500 Nymox Pharmaceutical Corp shares in Q4 2019, an estimated $987.
Nymox Pharmaceutical Corp made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4463 holding.
Ladenburg Thalmann Financial Services first reported a position in Nymox Pharmaceutical Corp in Q3 2013 and has held it in 26 quarters since.
Ladenburg Thalmann Financial Services's Nymox Pharmaceutical Corp position peaked at $82K in Q3 2013.
45 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.